The pediatric cardiology pharmacopoeia: 2004 Update

Pediatric Cardiology

Volumn 25, Issue 6, 2004, Pages 623-646

  Barnes, S ^a   Shields, B ^a   Bonney, W ^a   Hardin, J ^b   Abdulla, R ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Analgesics; Antiarrhythmic; Congenital heart disease; Diuretics; Inhalation pulmonary vasodilators; Inotropes; Medications; Pediatric; Sedatives; Subacute bacterial endocarditis prophylaxis; Vasodilators

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ADENOSINE; ADRENALIN; ALTEPLASE; AMIODARONE; AMRINONE; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ATENOLOL; BUMETANIDE; CALCIUM CHLORIDE; CAPTOPRIL; CENTIN; CHLORAL HYDRATE; CHLOROTHIAZIDE; CHLORPROMAZINE; CLONIDINE; DEXAMETHASONE; DIAZEPAM; DIAZOXIDE; DIGOXIN; DIPHENHYDRAMINE; DISOPYRAMIDE PHOSPHATE; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENALAPRIL MALEATE; ENOXAPARIN; ESMOLOL; ETACRYNIC ACID; FENTANYL CITRATE; FLECAINIDE ACETATE; FLUMAZENIL; FUROSEMIDE; GLUCONATE CALCIUM; GLYCERYL TRINITRATE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; IBUPROFEN; INDOMETACIN; ISOPRENALINE; KETAMINE; KETOROLAC; LEVALBUTEROL; LIDOCAINE; LORAZEPAM; METOLAZONE; METOPROLOL TARTRATE; MIDAZOLAM; MILRINONE; MORPHINE SULFATE; NESIRITIDE; NICARDIPINE; NIFEDIPINE; NIPRID; NITRO BID; NITROPRUSSIDE SODIUM; NORADRENALIN; PANCURONIUM BROMIDE; PETHIDINE; PHENYLEPHRINE; PHENYTOIN; PHYTOMENADIONE; PRAZOSIN; PROCAINAMIDE; PROMETHAZINE; PROPAFENONE; PROPRANOLOL; PROSTACYCLIN; PROSTAGLANDIN E2; PROVENTIL ACCUNEB; R GENE; ROCURONIUM; SALBUTAMOL; SEDATIVE AGENT; SOFATIN; SPIRONOLACTONE; UNINDEXED DRUG; VASODILATOR AGENT; VECURONIUM; VEELAN; VERAPAMIL; WARFARIN;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; AGITATION; AGRANULOCYTOSIS; ALOPECIA; AMENORRHEA; ANAPHYLAXIS; ANEMIA; ANGINA PECTORIS; ANOREXIA; ANXIETY DISORDER; APLASTIC ANEMIA; ARTHRALGIA; ATAXIA; ATRIOVENTRICULAR BLOCK; BACTERIAL ENDOCARDITIS; BLEEDING; BLOOD DYSCRASIA; BLOOD TOXICITY; BLURRED VISION; BONE MARROW SUPPRESSION; BRADYCARDIA; BRAIN HEMORRHAGE; BRONCHOSPASM; CAFFEY DISEASE; CATARACT; CHILL; CHOLESTASIS; CHRONIC LUNG DISEASE; CONFUSION; CONGESTIVE HEART FAILURE; CONSTIPATION; COOMBS TEST; CORNEA DISEASE; COUGHING; CUSHING SYNDROME; CYANIDE POISONING; DELIRIUM; DEPRESSION; DERMATITIS; DIAPHORESIS; DIARRHEA; DIZZINESS; DROWSINESS; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDICATION; DYSPEPSIA; DYSPHAGIA; DYSPNEA; EDEMA; EUPHORIA; EXFOLIATIVE DERMATITIS; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; EXTRASYSTOLE; FATIGUE; FLATULENCE; FLUID RETENTION; FLUSHING; FOLIC ACID DEFICIENCY; FRACTURE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL IRRITATION; GASTROINTESTINAL TOXICITY; GINGIVA HYPERPLASIA; GLAUCOMA; GYNECOMASTIA; HEADACHE; HEARING IMPAIRMENT; HEART ARRHYTHMIA; HEART BLOCK; HEART CATHETERIZATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE EXCITABILITY; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HEMATURIA; HEMOLYTIC ANEMIA; HEMOPTYSIS; HEPATITIS; HIRSUTISM; HUMAN; HYPERAMMONEMIA; HYPERCALCEMIA; HYPERCALCIURIA; HYPERCHLOREMIC ACIDOSIS; HYPERGLYCEMIA; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERMAGNESEMIA; HYPEROSMOLALITY; HYPERSALIVATION; HYPERTENSION; HYPERTHERMIA; HYPERTHYROIDISM; HYPERTROPHIC CARDIOMYOPATHY; HYPERURICEMIA; HYPERVENTILATION; HYPOALDOSTERONISM; HYPOCALCEMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; HYPOTHYROIDISM; HYPOVOLEMIA; INJECTION SITE PAIN; INOTROPISM; INSOMNIA; INTERSTITIAL NEPHRITIS; INTRACRANIAL PRESSURE; IRON DEFICIENCY ANEMIA; JAUNDICE; KETOACIDOSIS; KIDNEY FAILURE; LARYNX SPASM; LETHARGY; LEUKOPENIA; LIVER TOXICITY; LUNG EDEMA; LUNG FIBROSIS; LUPUS LIKE SYNDROME; LYMPHADENOPATHY; MEDICAL LITERATURE; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; METHEMOGLOBINEMIA; MICTURITION DISORDER; MIOSIS; MUSCLE CRAMP; MUSCLE SPASM; MYALGIA; MYOCARDIAL DISEASE; MYOCLONUS; MYOPATHY; NAUSEA; NEPHROLITHIASIS; NEPHROTOXICITY; NERVOUSNESS; NEURALGIA; NEUROTOXICITY; NEUTROPENIA; NOSE CONGESTION; NYSTAGMUS; OLIGURIA; ORTHOSTATIC HYPOTENSION; OSTEOMALACIA; OSTEOPOROSIS; OTOTOXICITY; PANCREATITIS; PARESTHESIA; PEDIATRIC CARDIOLOGY; PEPTIC ULCER; PERIPHERAL NEUROPATHY; PHLEBITIS; PHOTOPHOBIA; PHOTOSENSITIVITY; POLYURIA; POSTOPERATIVE CARE; PROTEINURIA; PSYCHOSIS; PUBLICATION; PULMONARY HYPERTENSION; QRS COMPLEX; QT PROLONGATION; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; RESTLESSNESS; REVIEW; SEDATION; SEIZURE; SHOCK; SIDE EFFECT; SINUS BRADYCARDIA; SKIN PIGMENTATION; SKIN TOXICITY; SODIUM RETENTION; SOMNOLENCE; STEVENS JOHNSON SYNDROME; STOMACH ULCER; SURGICAL TECHNIQUE; SWEATING; SYNCOPE; TACHYCARDIA; TACHYPNEA; TASTE DISORDER; THORAX PAIN; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPENIA; TINNITUS; TREMOR; UREMIA; URINE RETENTION; UTERUS CONTRACTION; VERTIGO; VOMITING; WATER RETENTION; WEAKNESS; WHEEZING; WITHDRAWAL SYNDROME; XEROSTOMIA;

CARDIOLOGY; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; HEART DISEASES; HUMANS; LUNG DISEASES; PEDIATRICS; PHARMACOPOEIAS; PRACTICE GUIDELINES;

EID: 31344481509     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-003-0692-z     Document Type: Review

References (25)

1. R Abdulla S Young S Barnes 1997 The pediatric cardiology pharmacopoeia Pediatr Cardiol 18 162 183
2. RJ Barst G Maislin A Fishman 1999 Vasodilator therapy for primary pulmonary hypertension in children Circulation 99 1971 1208
3. RJ Barst LJ Rubin WA Long 1996 A comparison of continuous intravenous epoprostenol (prostacylin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 296 301
4. M Beghetti W Habre B Friedli 1995 Continuous use of low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in pediatric patients Br Heart J 73 65 68
5. Guidelines British Cardiac Society Committee Medical Practice 2001 Recommendations on the management of pulmonary hypertension in clinical practice Heart 86 i1 i13
6. SQ Clavecilla T De Marco 2003 New insights into the treatment of pulmonary arterial hypertension Formulary 38 150 167
7. AS Dajani KA Taubert W Wilson 1997 Prevention of bacterial Endocarditis: recommendations by the American Heart Association J Am Med Assoc 277 1794 1801
8. JA de Lemos DK [tmp] McGuire MH Drazner 2003 B-type natriuretic peptide in cardiovascular disease Lancet 362 316 322
9. JT Flynn TA Mottes PD Brophy DB Kershaw WE Smoyer TE Bunchman 2001 Intravenous nicardipine for treatment of severe hypertension in children J Pediatr 139 38 43
10. VL Gunn C Nechyba 2000 The Harriet Lane Handbook 16 Mosby-Year Book St Louis 575 889
11. A Haraldsson N Kieler-Jensen U Nathorst-Westfelt C Bergh S Richsten 1998 Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance Chest 114 780 786
12. A Haraldsson N Kieler-Jensen S Richsten 1996 Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study J Cardiothoracic Vasc Anesth 10 864 868
13. A Haraldsson N Kieler-Jensen SE Ricksten 2001 The additive pulmonary vasodilatory effects of inhaled prostacylin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension Anesth Analg 93 1439 1445
14. MM Hoeper M Schwarze S Ehlerding 2000 Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue N Engl J Med 342 1866 1870
15. T Kawada H Kitagawa M Hoson Y Okada J Shiomura 2000 Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation Hematol Oncol Clin North Am 14 445 457
16. L Kelly N Porta D Goodman C Carroll R Steinhorn 2002 Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide J Pediatr 141 830 832
17. SM Lowson 2002 Inhaled alternatives to nitric oxide Anesthesiology 96 1504 1513
18. G Mikhail S Gibbs G Richardson G Wright A Khaghani N Banner 1997 An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension Eur Heart J 18 1499 1504
19. OI Miller SF Tang A Keech 2000 Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomized double-blind study Lancet 356 1464 1449
20. P Monagle AD Michelson E Bovill M Andrew 2001 Antithrombotic therapy in children Chest 119 344S 370S
21. FO Odetola V Bhatt-Mehta J Zahraa FW Moler JR Custer 2002 Cisatracurium infusion for neuromuscular blockade in the pediatric intensive care unit: a dose-finding study Pediatr Crit Care Med 3 250 254
22. H Olschewski D Walmrath R Schermuly 1996 Aerosolized prostacylin and iloprost in severe pulmonary hypertension Ann Int Med 124 820 824
23. A Solina D Papp S Ginsberg T Krause W Grubb 2000 A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients J Cardiothoracic Vasc Anesth 14 12 17
24. CK Taketomo JH Hodding DM Kraus 2002 Pediatric Dosage Handbook 9 Lexi-Comp Hudson, NY 28 1128
25. Tejani S, Nadkarni V (1999) Transdermal clonidine prophylaxis for narcotic withdrawal in critically ill children [Abstract]. Paper presented at the 8th annual meeting of the Pediatric Pharmacy Advocacy Group, Vancouver, Canada.